Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT07283913

Non-invasive Ultrasonic Auricular Vagus Nerve Stimulation

Led by University of Nottingham · Updated on 2025-12-16

30

Participants Needed

2

Research Sites

30 weeks

Total Duration

On this page

Sponsors

U

University of Nottingham

Lead Sponsor

U

University of Cambridge

Collaborating Sponsor

AI-Summary

What this Trial Is About

The Vagus nerve, one of 12 cranial nerves that connect the brain to the human body, controls specific involuntary functions such as breathing, heart rate, the digestive system and the immune system, and it is crucial to unlocking the relaxation response (parasympathetic nervous system). Vagus nerve stimulation (VNS) can be invasive or non-invasive, and both methods have been trialled in research studies. Some non-invasive VNS involves the use of a device which is placed on the skin, to send electrical impulses to the Vagus nerve. The device sends electrical impulses to some areas of the brain which changes brain activity and helps in treating certain disorders. Invasive methods utilise a surgically implanted Vagus nerve stimulator on the left Vagus nerve in the neck area. VNS is used in treatment of epilepsy and studies has shown to have a therapeutic effect on treatment resistant depression. Currently, research indicates that invasive VNS to treat anxiety yield mixed results, whilst other studies suggest that VNS with exposure-based therapies might enhance outcomes for anxiety patients. Stimulating the Vagus nerve comes with serious technical challenges. Most importantly, electric currents follow the path of least resistance. When running through biological tissues, such as skin, cartilage or bone, it is difficult to aim for the part of the body that needs to be stimulated. This means it isn't always easy to tell whether the Vagus nerve is indeed being stimulated and how much of the current is reaching the Vagus nerve. This problem can be overcome by ultrasound stimulation. Ultrasound stimulation employs high frequency sound waves to stimulate tissue. These soundwaves travel through the human body much more predictably than electric currents. As such, ultrasound stimulation of the Vagus nerve may be more effective than electrical stimulation. The ZenBud device is designed to apply ultrasound stimulation to part of the auricular branch of the Vagus nerve. Ultrasound stimulation allows for more targeted stimulation, increasing the chance of the stimulation reaching the Vagus nerve. The ZenBud device is safe for use in healthy adults and received CE marking. Before testing the therapeutic effect of the Zenbud on patients with symptoms it is important to identify physiological, cognition or emotional changes in health volunteers. Identifying these changes could lead to identifying possible future therapeutic uses for ultrasound-VNS (U-VNS).

CONDITIONS

Official Title

Non-invasive Ultrasonic Auricular Vagus Nerve Stimulation

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Willing and able to give informed consent for participation
  • Not currently taking any medications except contraceptive pill
  • Aged 18 years or older
  • In good general health
  • Able and willing to remove any piercings in the left ear
  • Able to abstain from exercise and fast from food for 12 hours before the second and third visits
Not Eligible

You will not qualify if you...

  • Current or past diagnosis of major neurological, neurosurgical, or psychiatric disorder including depression
  • Unable to complete informed consent process
  • Personal history of cardiac arrhythmia
  • Diabetes
  • High blood pressure (greater than 140 mmHg systolic and/or greater than 90 mmHg diastolic)
  • Other significant medical conditions including cardiological disorders (to be reviewed before inclusion)
  • Use of medications or recreational drugs affecting the nervous system in the past 3 months
  • Medication intake such as beta-blockers, glucocorticoids, antidepressants, anti-inflammatory drugs in the last 7 days (contraceptive medication allowed)
  • Currently pregnant or breastfeeding
  • Allergy to aquasonic gel or its components (propylene glycol, glycerin, isothiazolinones)
  • Participation in a research study in the last 3 months involving invasive procedures or inconvenience allowance
  • Body mass index less than 18 or greater than 30 kg/m²
  • Excessive alcohol consumption (more than 2 alcoholic drinks/day) or tobacco use (more than 5 cigarettes/day)
  • Previous experience with stress tests
  • Known infection in the last 8 weeks

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Neuromodulation Lab, Medical School, Queen's Medical Centre

Nottingham, Nottinghamshire, United Kingdom, NG7 2UH

Actively Recruiting

2

University of Nottingham

Nottingham, United Kingdom

Not Yet Recruiting

Loading map...

Research Team

A

Alicia Falcon-Caro, PhD

CONTACT

S

Stefanos A Kontogouris, MSc

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

BASIC_SCIENCE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Non-invasive Ultrasonic Auricular Vagus Nerve Stimulation | DecenTrialz